Ark Therapeutics gains wound care footwear
This article was originally published in Clinica
London, UK-based specialist healthcare group Ark Therapeutics has secured exclusive UK and international marketing rights to a medical footwear device developed by German surgical, trauma and woundcare specialist, Darco, for managing diabetic foot ulcers. Under the terms of the agreement, Darco will manufacture and supply the product to Ark, which, in turn, will be responsible for reimbursement and sales and marketing. The device, to be marketed as Kerraped, is already approved for reimbursement by the UK National Health Service.